Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Jasmine Bogaerts
Introduction
Jasmine Bogaerts is a notable inventor based in Mol, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. Her work is characterized by a focus on enhancing therapeutic options for various medical conditions.
Latest Patents
Jasmine Bogaerts holds a patent for the invention titled "Hemi (L)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1-indol-2-yl}methyl)-1-(2,2,2-trifluoroethy)-1,3-dihydro-2-imidazo[4,5-C]pyridin-2-one and pharmaceutical compositions comprising the same." This invention relates to hemi (L)-tartrate forms of the RSV fusion inhibitor known as rilematovir. The patent outlines processes for preparing these forms and their use in pharmaceutical compositions, showcasing her innovative approach to drug development.
Career Highlights
Jasmine is currently employed at Janssen Sciences Ireland Unlimited Company, where she continues to advance her research and development efforts. Her work at this esteemed organization highlights her commitment to improving healthcare through innovative solutions.
Collaborations
Throughout her career, Jasmine has collaborated with talented professionals, including Jan Jos L Bevernage and Kristof Leonard Kimpe. These collaborations have further enriched her research and contributed to the success of her projects.
Conclusion
Jasmine Bogaerts exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly her patented work, reflect her dedication to advancing medical science and improving patient outcomes.